Literature DB >> 28450071

Good cell culture practices &in vitro toxicology.

Chantra Eskes1, Ann-Charlotte Boström2, Gerhard Bowe2, Sandra Coecke2, Thomas Hartung3, Giel Hendriks4, David Pamies5, Alain Piton6, Costanza Rovida7.   

Abstract

Good Cell Culture Practices (GCCP) is of high relevance to in vitro toxicology. The European Society of Toxicology In Vitro (ESTIV), the Center for Alternatives for Animal Testing (CAAT) and the In Vitro Toxicology Industrial Platform (IVTIP) joined forces to address by means of an ESTIV 2016 pre-congress session the different aspects and applications of GCCP. The covered aspects comprised the current status of the OECD guidance document on Good In Vitro Method Practices, the importance of quality assurance for new technological advances in in vitro toxicology including stem cells, and the optimized implementation of Good Manufacturing Practices and Good Laboratory Practices for regulatory testing purposes. General discussions raised the duality related to the difficulties in implementing GCCP in an academic innovative research framework on one hand, and on the other hand, the need for such GCCP principles in order to ensure reproducibility and robustness of in vitro test methods for toxicity testing. Indeed, if good cell culture principles are critical to take into consideration for all uses of in vitro test methods for toxicity testing, the level of application of such principles may depend on the stage of development of the test method as well as on the applications of the test methods, i.e., academic innovative research vs. regulatory standardized test method.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Complex in vitro systems; Good cell culture practices; Good in vitro method practices; Good laboratory practices; Good manufacturing practices; Stem-cells

Mesh:

Year:  2017        PMID: 28450071     DOI: 10.1016/j.tiv.2017.04.022

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  8 in total

Review 1.  In vitro reconstructed 3D corneal tissue models for ocular toxicology and ophthalmic drug development.

Authors:  Yulia Kaluzhny; Mitchell Klausner
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-02-05       Impact factor: 2.416

2.  Profile of IL-6 and TNF in Foam Cell Formation: An Improved Method Using Fluorescein Isothiocyanate (FITC) Probe.

Authors:  Cynthia Aparecida Castro; Tereza Cristina Buzinari; Rafael Luis Bressani Lino; Heloisa Sobreiro Selistre de Araújo; Fernanda de Freitas Aníbal; Roberto Mario Machado Verzola; Vanderlei Salvador Bagnato; Natalia Mayumi Inada; Gerson Jhonatan Rodrigues
Journal:  Arq Bras Cardiol       Date:  2022-08-05       Impact factor: 2.667

3.  A Systematic Approach to Review of in vitro Methods in Brain Tumour Research (SAToRI-BTR): Development of a Preliminary Checklist for Evaluating Quality and Human Relevance.

Authors:  Mike Bracher; Geoffrey J Pilkington; C Oliver Hanemann; Karen Pilkington
Journal:  Front Bioeng Biotechnol       Date:  2020-08-07

4.  3S - Systematic, systemic, and systems biology and toxicology.

Authors:  Lena Smirnova; Nicole Kleinstreuer; Raffaella Corvi; Andre Levchenko; Suzanne C Fitzpatrick; Thomas Hartung
Journal:  ALTEX       Date:  2018       Impact factor: 6.043

5.  Single-Cell Analysis Reveals that Chronic Silver Nanoparticle Exposure Induces Cell Division Defects in Human Epithelial Cells.

Authors:  Ellen B Garcia; Cynthia Alms; Albert W Hinman; Conor Kelly; Adam Smith; Marina Vance; Jadranka Loncarek; Linsey C Marr; Daniela Cimini
Journal:  Int J Environ Res Public Health       Date:  2019-06-11       Impact factor: 3.390

6.  In Vitro Research Reproducibility: Keeping Up High Standards.

Authors:  Cordula Hirsch; Stefan Schildknecht
Journal:  Front Pharmacol       Date:  2019-12-10       Impact factor: 5.810

Review 7.  The Hitchhiker's Guide to Human Therapeutic Nanoparticle Development.

Authors:  Thelvia I Ramos; Carlos A Villacis-Aguirre; Katherine V López-Aguilar; Leandro Santiago Padilla; Claudia Altamirano; Jorge R Toledo; Nelson Santiago Vispo
Journal:  Pharmaceutics       Date:  2022-01-21       Impact factor: 6.321

8.  Quality Control Platform for the Standardization of a Regenerative Medicine Product.

Authors:  Silvia Zia; Barbara Roda; Chiara Zannini; Francesco Alviano; Laura Bonsi; Marco Govoni; Leonardo Vivarelli; Nicola Fazio; Dante Dallari; Pierluigi Reschiglian; Andrea Zattoni
Journal:  Bioengineering (Basel)       Date:  2022-03-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.